Bausch Health Co. Inc. (BHC) reported Q4 EPS of ($1.13), $2.01 worse than the analyst estimate of $0.88. Revenue for the quarter came in at $2.19 billion versus the consensus estimate of $2.14 billion.
Bausch Health Co. Inc. (BHC) reported Q4 EPS of ($1.13), $2.01 worse than the analyst estimate of $0.88. Revenue for the quarter came in at $2.19 billion versus the consensus estimate of $2.14 billion.